228 related articles for article (PubMed ID: 34738626)
1. Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.
Ito K; Kitajima Y; Kai K; Matsufuji S; Yamada K; Egawa N; Kitagawa H; Okuyama K; Tanaka T; Noshiro H
Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34738626
[TBL] [Abstract][Full Text] [Related]
2. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor-1α and Wnt/β-catenin signaling pathways promote the invasion of hypoxic gastric cancer cells.
Liu HL; Liu D; Ding GR; Liao PF; Zhang JW
Mol Med Rep; 2015 Sep; 12(3):3365-3373. PubMed ID: 25997455
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines.
Baba K; Kitajima Y; Miyake S; Nakamura J; Wakiyama K; Sato H; Okuyama K; Kitagawa H; Tanaka T; Hiraki M; Yanagihara K; Noshiro H
Sci Rep; 2017 Sep; 7(1):11127. PubMed ID: 28894280
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
[TBL] [Abstract][Full Text] [Related]
6. 14-3-3 Sigma Protein Contributes to Hepatocyte Growth Factor-mediated Cell Proliferation and Invasion
Jung JY; Koh SA; Lee KH; Kim JR
Anticancer Res; 2022 Jan; 42(1):519-530. PubMed ID: 34969762
[TBL] [Abstract][Full Text] [Related]
7. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
[TBL] [Abstract][Full Text] [Related]
8. CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression.
Sun X; Wei L; Chen Q; Terek RM
Mol Cancer; 2010 Jan; 9():17. PubMed ID: 20102637
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer.
Guo ZJ; Yang L; Qian F; Wang YX; Yu X; Ji CD; Cui W; Xiang DF; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Oncotarget; 2016 Apr; 7(15):20999-1012. PubMed ID: 27007162
[TBL] [Abstract][Full Text] [Related]
10. Impaired mitophagy activates mtROS/HIF-1α interplay and increases cancer aggressiveness in gastric cancer cells under hypoxia.
Shida M; Kitajima Y; Nakamura J; Yanagihara K; Baba K; Wakiyama K; Noshiro H
Int J Oncol; 2016 Apr; 48(4):1379-90. PubMed ID: 26820502
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of MMP‑1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/c‑myc signaling pathway and EMT.
Wang K; Zheng J; Yu J; Wu Y; Guo J; Xu Z; Sun X
Oncol Rep; 2020 Apr; 43(4):1103-1112. PubMed ID: 32323782
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
13. The role of TRPV1 ion channels in the suppression of gastric cancer development.
Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer.
Gan L; Meng J; Xu M; Liu M; Qi Y; Tan C; Wang Y; Zhang P; Weng W; Sheng W; Huang M; Wang Z
Oncogene; 2018 Feb; 37(6):744-755. PubMed ID: 29059156
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of NCOA2 Inhibits the Growth and Progression of Gastric Cancer by Affecting the Wnt Signaling Pathway-Related Protein Expression.
Lin Z; Yang F; Lu D; Sun W; Zhu G; Lan B
Technol Cancer Res Treat; 2020; 19():1533033820928072. PubMed ID: 32489143
[TBL] [Abstract][Full Text] [Related]
16. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.
Yamaguchi T; Fushida S; Yamamoto Y; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Tajima H; Ninomiya I; Munesue S; Harashima A; Harada S; Yamamoto H; Ohta T
Gastric Cancer; 2016 Oct; 19(4):1052-1065. PubMed ID: 26621525
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
19. Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer.
Yu S; Li Q; Yu Y; Cui Y; Li W; Liu T; Liu F
Cancer Immunol Immunother; 2020 Oct; 69(10):1973-1987. PubMed ID: 32388677
[TBL] [Abstract][Full Text] [Related]
20. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
